Health apps: Working smarter, not just harder
The myriad ways digital tools could change everything for pharma and the NHS
Read More
Search Results for: Martin Parkinson
AlzeCure delivers positive NeuroRestore candidate results
The therapy reaches and activates areas of the brain that are central to cognitive enhancement
Read More
AlzeCure’s promising Alzheimer’s abstract accepted
ACD856 has also been shown across preclinical studies to improve cognition and memory
Read MoreElan cleaves discovery activities into Neotope
Irish drugmaker Elan has announced the spin off of its discovery science and Neotope Biosciences into a separate business entity “to create two independent, highly focused, public companies”.
Read MoreIMI, CDISC hook up for standardised data management
The Innovative Medicines Initiative (IMI) has announced an agreement with the US-based Clinical Data Interchange Standards Consortium (CDISC) that will see IMI project teams adopt CDISC formats and standards to harmonise data management across the two organisations.
Read More- 1
- 2
- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
